株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

コンパニオン診断(CDx)の世界市場 2019年〜2023年

Global Companion Diagnostics Market 2019-2023

発行 TechNavio (Infiniti Research Ltd.) 商品コード 298805
出版日 ページ情報 英文 118 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.55円で換算しております。
Back to Top
コンパニオン診断(CDx)の世界市場 2019年〜2023年 Global Companion Diagnostics Market 2019-2023
出版日: 2018年12月31日 ページ情報: 英文 118 Pages
概要

コンパニオン診断(CDx)は、その特異性のため、市場で入手可能な他の検査キットなどのように広く流通していません。そのため、流通ネットワークの改善とエンドユーザーへの入手性を向上させることに重点的に取り組む必要性があります。コンパニオン診断(CDx)の世界市場は、2023年にかけておよび25%のCAGRで推移すると予測されています。

当レポートでは、世界のコンパニオン診断(CDx)市場を調査し、市場の概要、エンドユーザー・地域別の市場規模の推移と予測、市場の成長要因および課題の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポート範囲

第3章 市場状況

  • 市場エコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模
  • 市場規模の予測

第5章 ファイブフォース分析

  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場区分:エンドユーザー別
  • 市場比較:エンドユーザー別
  • ライフサイエンス
  • ヘルスセンター
  • その他
  • 市場機会:エンドユーザー別

第7章 顧客情勢

第8章 市場セグメンテーション:地域別

  • 市場区分:地域別
  • 市場区分:地域別
  • 欧州・中東・アフリカ
  • アジア太平洋地域
  • 主要国
  • 市場機会

第9章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第10章 市場動向

第11章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott
  • Agilent Technologies
  • F. Hoffmann-La Roche
  • QIAGEN
  • Thermo Fisher Scientific

第13章 付録

  • 調査方法
  • 略語のリスト
図表
  • Exhibit 01: Years in consideration
  • Exhibit 02: Global medical devices market
  • Exhibit 03: Segments of global medical devices market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: End-user - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Life science - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Life science - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Health centers - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Health centers - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 25: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 26: Market opportunity by end-user
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2018-2023 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: Americas - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Americas - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: EMEA - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: EMEA - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: APAC - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: APAC - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Decision framework
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Abbott - Vendor overview
  • Exhibit 46: Abbott - Business segments
  • Exhibit 47: Abbott - Organizational developments
  • Exhibit 48: Abbott - Geographic focus
  • Exhibit 49: Abbott - Segment focus
  • Exhibit 50: Abbott - Key offerings
  • Exhibit 51: Agilent Technologies - Vendor overview
  • Exhibit 52: Agilent Technologies - Business segments
  • Exhibit 53: Agilent Technologies - Organizational developments
  • Exhibit 54: Agilent Technologies - Geographic focus
  • Exhibit 55: Agilent Technologies - Segment focus
  • Exhibit 56: Agilent Technologies - Key offerings
  • Exhibit 57: F. Hoffmann-La Roche - Vendor overview
  • Exhibit 58: F. Hoffmann-La Roche - Business segments
  • Exhibit 59: F. Hoffmann-La Roche - Organizational developments
  • Exhibit 60: F. Hoffmann-La Roche - Geographic focus
  • Exhibit 61: F. Hoffmann-La Roche - Segment focus
  • Exhibit 62: F. Hoffmann-La Roche - Key offerings
  • Exhibit 63: QIAGEN - Vendor overview
  • Exhibit 64: QIAGEN - Business segments
  • Exhibit 65: QIAGEN - Organizational developments
  • Exhibit 66: QIAGEN - Geographic focus
  • Exhibit 67: QIAGEN - Segment focus
  • Exhibit 68: QIAGEN - Key offerings
  • Exhibit 69: Thermo Fisher Scientific - Vendor overview
  • Exhibit 70: Thermo Fisher Scientific - Business segments
  • Exhibit 71: Thermo Fisher Scientific - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific - Segment focus
  • Exhibit 74: Thermo Fisher Scientific - Key offerings
  • Exhibit 75: Validation techniques employed for market sizing
  • Exhibit 76: List of abbreviations
目次
Product Code: IRTNTR30609

About this market:

The growing importance for promotional activities to drive market growth. The companion diagnostics are not as frequently marketed like other test kits and devices that are available in the market due to its specificity, wherein it can be used only for a drug. Therefore, more emphasis must be provided toward improving distribution network and increasing the product availability to end-users. Online media and search engines are the primary sources for advertising, owing to the low return on investment and limited visibility of other media. Technavio's analysts have predicted that the companion diagnostics market will register a CAGR of almost 25% by 2023.

Market Overview:

Rising use of personalized medicine

Personalized medicine is a multi-faceted method to patient care that not only improves capacity to diagnose and treat diseases but offers the potential to distinguish diseases at an earlier stage, which makes it easier for practitioners to treat effectively. With its specificity in treating particular disease based on individual's genetic characteristics, personalized medicine is gaining popularity.

Lack of manpower

Companion diagnostic tests are highly technical, and care must be taken at each step to facilitate a successful execution of these tests, to generate reproducible results. A major challenge in these scientific fields is the lack of technically skilled and trained staff.

For the detailed list of factors that will drive and challenge the growth of the companion diagnostics market during the 2019-2023, view our report.

Competitive Landscape:

The market appears to be fragmented and with the presence of several companies including Abbott and Agilent Technologies the competitive environment is quite intense. Factors such as the rising use of personalized medicine and the growing importance for promotional activities, will provide considerable growth opportunities to companion diagnostics manufactures. Abbott, Agilent Technologies, F. Hoffmann-La Roche, QIAGEN, and Thermo Fisher Scientific are some of the major companies covered in this report.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1. Preface
  • 2.2. Preface
  • 2.3. Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Life science - Market size and forecast 2018-2023
  • Health centers - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Agilent Technologies
  • F. Hoffmann-La Roche
  • QIAGEN
  • Thermo Fisher Scientific

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations
Back to Top